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A B S T R A C T
Infection caused by Klebsiella pneumoniae, Acinetobacter baumannii and Enterococcus faecium can be diﬃcult to
treat. New biocidal products are needed in order to reduce the transmission of such bacteria from surfaces to
patients. This fundamental study aimed to investigate the antimicrobial eﬃcacy of nine metal ion solutions
(yttrium, indium, niobium, titanium, tantalum, rhodium, ruthenium, zinc and gallium) using zone of inhibition
(ZoI), minimum inhibitory concentration (MIC) and minimum bactericidal concentrations (MBC). Fractional
inhibitory concentration (FIC) and fractional bactericidal concentration (FBC) assays were used to determine
antimicrobial activities of various combinations. The rhodium metal ion solution when applied singly demon-
strated the best antimicrobial eﬃcacies against all the bacteria tested. FICs indicated that the rhodium/ruthe-
nium combination was either synergistic or additive against all three tested bacteria. This metal ion combination
also exhibited synergistic activity against E. faecium following in FBCs. Our data presented indicated the po-
tential of the rhodium and/or ruthenium metal ions for antisepsis, disinfection and for incorporation into hy-
gienic surfaces.
1. Introduction
There has been a rise in the number of multidrug resistant (MDR)
bacterial infections in hospital settings leading to increased mortality,
morbidity, hospitalization and treatment costs (Olar et al., 2010). It is
estimated that 9% of in-patients in England and Wales suﬀer from
hospital-acquired infections, which is reported to result in around 5000
deaths and extra care related costs of over £1 billion per year. These
infections are caused in part by transmission across the wards (Smith
and Hunter, 2008). There are a number of pathogens that are demon-
strating increasing resistance from the biocidal action of antimicrobial
agents, producing a new mode of pathogenesis (Pendleton et al., 2013).
Klebsiella pneumoniae, Acinetobacter baumannii and Enterococcus faecium
are three such bacteria out of the six ‘ESKAPE’ pathogens that are
considered to be a leading cause of nosocomial infections (Santajit and
Indrawattana, 2016). Such bacteria may persist on hospital and bio-
material surfaces including catheters, stethoscopes and disinfectant
soap dispensers (Smith and Hunter, 2008). Ampicillin and vancomycin
resistant E. faecium has demonstrated a constant threat in the incidence
of health-care infections (Pendleton et al., 2013). In recent times, K.
pneumoniae and A. baumannii have acquired the ability to synthesize a
variety of beta-lactamase enzymes that can destroy the chemical
structure of beta-lactam antibiotics, thus making these bacteria multi-
drug resistant (Santajit and Indrawattana, 2016).
The lack of potential antimicrobial agents against such bacteria is a
major cause for concern. Thus, there is a need to develop novel ap-
proaches to prevent the transmission of bacteria that cause such in-
fections (Santos et al., 2014). Metals such as molybdenum, titanium and
tantalum have been used as biomaterials coatings on implants to de-
crease the bacterial adherence (Ribeiro et al., 2016; Chang et al., 2014;
Haenle et al., 2011). Rhodium complexes with tetraaza macrocyclic and
ruthenium (II) carbonyl thiosemicarbazone complexes have been
shown to have eﬀective antimicrobial eﬃcacy against range of bacteria
(Bien et al., 1999; Kannan et al., 2008; Jayabalakrishnan and Natarajan,
2002). Gallium and zinc ions co-ordinated with protoporphyrin and
mesoprotoporphyrin respectively have showed up to 90% antibacterial
eﬃcacy against Staphylococcus epidermis and Pseudomonas aeruginosa
(Ma et al., 2013). Titanium and its alloys have been used in various
medical implants such as bone screws, dental restorations and artiﬁcial
joints owing to their biocompatibility and also reputedly due to their
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bactericidal properties (He et al., 2017). This fundamental study in-
vestigated the antimicrobial eﬃcacy of nine metal ion solutions in-
dividually and in combination against K. pneumoniae, A. baumannii and
E. faecium to determine if they might provide potential biocidal solu-
tions.
2. Materials and methods
2.1. Cultures and media
Enterococcus faecium NCTC 7171 was cultured onto Columbia blood
agar (Oxoid, UK) (supplemented with 20mL deﬁbrinated horse blood),
incubated in 5% CO2 for 24 h at 37 °C in static conditions. K. pneumo-
niae NCTC 9633 and A. baumannii NCTC 12156 were cultured onto
Nutrient agar (NA) (Oxoid, UK) and incubated for 24 h at 37 °C. Brain
heart infusion (BHIA) agar (Oxoid, UK) and brain heart infusion broth
(BHIB) (Oxoid, UK) (E. faecium) and nutrient agar and nutrient broth
(NB) (Oxoid, UK) (K. pneumoniae or A. baumannii) were used for all
subsequent experiments and were incubated as above (Vaidya et al.,
2017).
2.2. Preparation of metal ion solutions
Standard solutions of 1000mg L−1 of yttrium (Y2O3 + HNO3), ti-
tanium (Ti metal + HNO3), tantalum (Ta metal + HNO3 (HF traces)),
indium (In metal + HNO3), niobium (Nb metal + HNO3 (HF traces)),
rhodium (RhCl3 + HCl), ruthenium (Re metal + HNO3), zinc (Zn
metal + HNO3) and gallium (Ga metal + HNO3) (Sigma-Aldrich, UK)
were used and diluted with sterile water to obtain 500mg L−1,
100mg L−1 and 50mg L−1 metal concentrations.
2.3. Bacterial preparation
The appropriate broth was inoculated with a single colony of bac-
teria and incubated overnight according to the aforementioned condi-
tions. Cells were harvested at 567 g for 10min and washed using sterile
distilled water three times for the ZoI test and double strength broth for
cells to be used in the MIC/MBC tests. Cells were re-harvested by
centrifugation for 10min at 567 g and adjusted using sterile distilled
water to an optical density (OD) 1.0 ± 0.1. The colony forming units
per mL (CFU mL−1) were calculated and cell concentrations corre-
sponded to K. pneumoniae 2.82×108, A. baumanii 1.85×108 and E.
faecium 3.95×108
2.4. Zone of inhibition (ZoI) assays
One hundred microliters of prepared cell suspension was spread
across the agar and three wells (8 mm diameter) were cut from the agar.
One hundred microliters of the metal ion solution (at diﬀerent metal
ion solution concentrations, 50mg L−1, 100mg L−1, 500mg L−1 and
1000mg L−1) was added to the well and the plates were incubated as
speciﬁed above. The radius of inhibition was measured in mm to de-
termine the average mean value (n=12).
2.5. Minimum inhibitory concentration (MIC) and minimum bactericidal
concentration (MBC) assays (adapted form Vaidya et al., 2017)
To 9mL of cell suspension, one mL of triphenyl tetrazolium chloride
(TTC) blue metabolic dye (Sigma-Aldrich, UK), was added. One hun-
dred microliters of bacterial suspension with the TTC dye and the metal
ion solutions was added to a 96 well ﬂat-bottomed micro titre plate.
The ﬁrst column of was mixed, and subsequent 100 μL of the sample/
bacterial mix was transferred to sequential wells and repeated until
column 10, whereby 100 μL of the mixture was disposed of. A positive
control and a negative control was carried out at the same time. The
MIC was taken as lowest concentration that inhibited the visible growth
of the bacteria, indicated by a change of colour to blue. From the ﬁrst
well that showed no growth and the last well that demonstrated
growth, 25 μL of suspension was pipetted onto agar and incubated. The
lowest concentration that showed no bacterial growth was determined
to be the MBC (n=3).
2.6. Fractional inhibitory concentrations (FIC) and fractional bactericidal
concentrations (FBC) index
This method was adapted from Vaidya et al. (2017). In brief, the
MIC and MBC metal ion solution synergies were determined using FIC
and FBC antimicrobial screening respectively. Both metal ion solutions
were added in a 1:1 ratio to the wells. The FIC and FBC values were
calculated using the following formula; ΣFIC or FBC = FIC or FBC of
antimicrobial A + FIC or FBC of antimicrobial B = [1]
+
MIC or MBC of antimicrobial A in combination
MIC or MBC of antimicrobial A alone
MIC or MBC of antimicrobial B in combination
MIC or MBC of antimicrobial B alone
The antimicrobial interaction was evaluated as≤ 0.5= synergy,>
0.5≤ 1=additivity,>1≤ 4=autonomy and>4=antagonism
(Doern, 2014) (n=3).
2.7. Statistical analysis
The average values were used to compare the results and standard
error to determine the distributions of the data. The intervals at 95%
conﬁdence were also determined.
3. Results
The nine metal ion solutions showed varying levels of toxicity
against the bacteria. The metal ions were in an acidic solution and
control assays were carried out to determine the eﬀects of the acids on
bacterial viability. It was found that the acids did not signiﬁcantly aﬀect
the results (data not shown).
3.1. Zone of inhibition
The ZoI results displayed a signiﬁcant increase in antimicrobial
activity with an increase in concentration (p < 0.05). At a concentra-
tion of 1000mg L−1 the rhodium metal ion solution was the most an-
timicrobial (11.5 mm, 12.5 mm and 7mmK. pneumonia, A. baumannii
and E. faecium respectively) followed by ruthenium for K. pneumonia
(10.66 mm) and A. baumannii (8mm) with antimicrobial eﬃcacy de-
monstrated for titanium and tantalum against E. faecium (both at 5mm)
(Fig. 1). Overall, at low concentrations, the least antimicrobially ef-
fective metal ion solutions were yttrium and zinc. With the exception of
titanium ion solution, all the metal ion solutions demonstrated no an-
timicrobial eﬃcacy at lower concentrations (50mg L−1 and
100mg L−1) against E. faecium (Fig. 1) (p > 0.05). Thus, Enterococcus
faecium was found to be the most resistant at all the metal ion solutions
tested concentrations.
3.2. Minimum inhibitory and bactericidal concentrations
Following the MIC assay, the rhodium and tantalum metal ion so-
lution showed the best antimicrobial eﬃcacy against all the tested
bacteria (7.81mg L−1 against the Gram-negative bacteria and
31.25mg L−1 against E. faecium). The ruthenium metal ion solution was
also inhibitory against A. baumannii and E. faecium (7.81mg L−1 and
31.25mg L−1 respectively) and the titanium metal ion solution was also
inhibitory against E. faecium (31.25mg L−1). The zinc ion solution
against all three bacteria (31.25mg L−1 K. pneumoniae and A. bau-
mannii; 125.00mg L−1 against E. faecium) and the yttrium ion solution
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(31.25 mg L−1 and A. baumannii; 125.00mg L−1 against E. faecium)
demonstrated the least antimicrobial inhibition (Table 1).
Following the MBC assays, only the rhodium and the ruthenium
demonstrated bactericidal activity against all thee bacteria
(15.62 mg L−1, 7.81mg L−1 and 62.50mg L−1 against K. pneumonia, A.
baumannii and E. faecium respectively). Against K. pneumoniae, tita-
nium, tantalum and gallium demonstrated bactericidal activity
(15.62 mg L−1), and against E. faecium tantalum and gallium also de-
monstrated bactericidal activity (15.62 mg L−1 and 62.50mg L−1 re-
spectively). The least bactericidal solutions were niobium (K. pneumo-
niae 46.87mg L−1), zinc, indium and yttrium (A. baumannii
15.62mg L−1) and zinc (E. faecium 250.00mg L−1) (Table 2). In both of
the tests, E. faecium was found to be the most resistant bacteria.
3.3. Fractional inhibitory concentrations and FBC index
The FIC (Table 3) and FBC was used to determine the synergistic
antimicrobial eﬃcacy of the metal ion solutions in combination. Fol-
lowing the FIC test, against K. pneumoniae only the rhodium/ruthenium
combination demonstrated an additive eﬀect (0.74). All the metal ion
solution combinations demonstrated additivity eﬀects against A. bau-
mannii (0.74–0.99) and E. faecium (0.99).
Following the FBC synergy assay (Table 4), only the rhodium/ru-
thenium combination demonstrated a synergistic antimicrobial eﬃcacy
against Gram-positive E. faecium (FBC=0.48) (Table 4). The titanium/
Fig. 1. The ZoI in millimetre for nine metal ion solutions against a) K. pneumoniae b) A. baumannii and c) E. faecium demonstrated the best antimicrobial eﬃcacy for
rhodium (n= 12). Y = Yttrium, Ti= titanium, Ta = Tantalum, In = Indium, Nb = Niobium, Rh = Rhodium, Ru = Ruthenium, Zn=Zinc and Ga = Gallium.
Table 1
Minimum inhibitory concentrations in mg/L for nine metal ion solutions
against three tested pathogens demonstrating the best antimicrobial eﬃcacy for
rhodium and titanium ion solutions (n= 3).
Metal ion solutions K. pneumoniae A. baumannii E. faecium
Zinc 31.25 ± 0 31.25 ± 0 125.00 ± 0
Titanium 15.62 ± 0 15.62 ± 0 31.25 ± 0
Tantalum 7.81 ± 0 7.81 ± 0 31.25 ± 0
Indium 15.62 ± 0 15.62 ± 0 62.50 ± 0
Yttrium 15.62 ± 0 31.25 ± 0 125.00 ± 0
Rhodium 7.81 ± 0 7.81 ± 0 31.25 ± 0
Ruthenium 15.62 ± 0 7.81 ± 0 31.25 ± 0
Gallium 15.62 ± 0 11.75 ± 2.76 62.50 ± 0
Niobium 15.62 ± 0 15.62 ± 0 62.50 ± 0
M. Vaidya et al. International Biodeterioration & Biodegradation xxx (xxxx) xxx–xxx
3
tantalum (0.75), titanium/rhodium (0.75) and titanium/ruthenium
(0.56) combinations demonstrated an additive antimicrobial eﬀect
against E. faecium. Overall, K. pneumoniae was found to the most re-
sistant bacteria for the dual combinations tested, whilst E. faecium was
found to the most sensitive bacteria in the FIC and FBC assays.
4. Discussion
The reoccurrence of MDR infections poses a great risk to public
health. The development of novel antimicrobial agents and biocides to
control and prevent the transmission of bacteria associated with hos-
pital-acquired infections is in need of exploration (Haenle et al., 2011).
This study found that the rhodium ion solution showed the best anti-
microbial eﬃcacies when tested alone or in combinations. The diﬀer-
ences in the antimicrobial eﬃcacies of the metal ions antimicrobial
action may be due to their mechanisms of action. The antimicrobial
activity of metals may be due to single or combined mechanisms such as
enzyme disruption, cell-membrane/cell-wall degradation, deoxyr-
ibonucleic acid denaturation, protein dysfunction or oxidative stress
(Lemire et al., 2013; Bruins et al., 2000; Varkey, 2010; Mitchell and
Kogure, 2006). It has been suggested that physical contact of metal ions
with the bacterial cell wall and internalization in the cell might cause
oxidization of the cellular components generating reactive oxygen
species and interruption of the transmembrane electron transport chain
(Dizaj et al., 2014; Kolmas et al., 2014). The antibacterial activity of the
rhodium metal ion solution may be due to its liposolubility, electro-
negativity and initiation of redox reactions (Lemire et al., 2013;
Beloglazkina et al., 2016). Rhodium metal possesses liposolubility
properties, which is suggested to favour its cell permeability aiding in a
greater transport inside a bacterial cell membrane (Bien et al., 1999).
Inside the bacterial cell, the higher electronegativity of rhodium (2.28)
might demonstrate an increase aﬃnity for amine, phosphate or sulf-
hydryl groups compared to other tested metal ion solutions (for ex-
ample Y= 1.22 or In=1.78) (Beloglazkina et al., 2016; Varkey, 2010).
Rhodium being a member of d-block transition metals possesses a
tendency to lose electrons and be reduced (Greenwood et al., 1998).
This redox reaction between rhodium ions and phosphate/amine/sulf-
hydryl groups may possibly aﬀect two vital processes inside the bac-
terial cell. Firstly, rhodium can bind to the large cavities of the ribo-
some, such as the peptide-conducting tunnel passing through the
ribosomal subunit. Secondly, it might hinder the translation and tran-
scription process required for the RNA and DNA formation. Thus, this
two-way redox reaction leads to protein dysfunction and ultimately
destruction of bacteria cell (Beloglazkina et al., 2016; Bien et al., 1999).
It is known that by adding antimicrobial substances together, a sy-
nergistic, additive, indiﬀerent or antagonistic result might occur
(Doern, 2014). In combination, the most eﬀective metal ion solution
was demonstrated to be rhodium/ruthenium. In agreement with our
results, rhodium complexes with tetraaza macrocyclic and ruthenium
(II) carbonyl thiosemicarbazone complexes have been shown to have
eﬀective antimicrobial eﬃcacy against range of bacteria (Bien et al.,
1999; Kannan et al., 2008; Jayabalakrishnan and Natarajan, 2002).
Further, a rhodium (III) ion complex with tetradentate macrocyclic was
shown to demonstrate inhibitory eﬃcacy when compared to platinum
(II) and iridium (II) complexes against E. coli and S. aureus (Chandra
et al., 2011). Further studies are needed to understand the mode of
action of the antimicrobials when used in combination.
This study also demonstrated that tantalum and titanium had some
antimicrobial properties. In respect to the other metal ion solutions
tested, various values have been previously reported, which seem to be
dependent on the formulation of the antimicrobial compounds. In our
work, the antimicrobial activity of titanium metal ion solutions was
demonstrated. Bis(cyclopentadienyl)titanium (IV) at 1000 ppm has
been show to demonstrate greater antimicrobial eﬃcacy using the ZoI
assay (up to 26mm) than when used without a titanium (IV) complex
(up to 16mm) against E. coli, S. aureus and Bacillus subtilis (Srivastava
et al., 2005; Cai et al., 2012). Surfaces coated with 80% titanium have
also been shown to have signiﬁcant antibacterial properties against E.
coli in a bacterial adhesion test (Seddiki et al., 2014). In work by others,
tantalum oxynitride thin ﬁlms were shown to have little antibacterial
eﬃcacy unless combined with silver ions using visible light radiation
against E. coli (Hsieh et al., 2010). Gallium and zinc ions co-ordinated
Table 2
Minimum bactericidal concentrations in mg/L for nine metal ion solutions
against three tested pathogens demonstrating the best antimicrobial eﬃcacy for
Ru and Rh ion solutions (n=3).
Metal ion solutions K. pneumoniae A. baumannii E. faecium
Zinc 31.25 ± 0 31.25 ± 0 250.00 ± 0
Titanium 15.62 ± 0 15.62 ± 0 125.00 ± 0
Tantalum 15.62 ± 0 15.62 ± 0 62.50 ± 0
Indium 31.25 ± 0 31.25 ± 0 125.00 ± 0
Yttrium 23.43 ± 5.52 31.25 ± 0 125.00 ± 0
Rhodium 15.62 ± 0 7.81 ± 0 62.50 ± 0
Ruthenium 15.62 ± 0 7.81 ± 0 62.50 ± 0
Gallium 15.62 ± 0 15.62 ± 0 62.50 ± 0
Niobium 46.87 ± 11.04 15.62 ± 0 125.00 ± 0
Table 3
Fractional inhibitory concentration index for six tested metal ion solutions combinations demonstrating combined eﬀects for all metal ion solutions against K.
pneumoniae, A. baumanii and E. faecium. FIC index=≤ 0.50= synergy,> 0.50≤ 1.00= additivity,> 1.00≤ 4.00= autonomy and>4.00= antagonism.
Titanium/Tantalum Titanium/Rhodium Titanium/Ruthenium Tantalum/Rhodium Tantalum/Ruthenium Rhodium/Ruthenium
K. pneumoniae 1.50 1.50 1.00 2.00 3.00 0.74
A. baumannii 0.74 0.74 0.74 0.99 0.99 0.99
E. faecium 0.99 0.99 0.99 0.99 0.99 0.99
Table 4
Minimum bactericidal concentration synergy index demonstrating combined eﬀects of antimicrobial activity for metal ions against K. pneumoniae, A. baumanii and E.
faecium. FBC index=≤ 0.50= synergy,> 0.50≤ 1.00= additivity, > 1.00≤ 4.00= autonomy and>4.00= antagonism.
Titanium/
Tantalum
Titanium/Rhodium Titanium/Ruthenium Tantalum/Rhodium Tantalum/Ruthenium Rhodium/Ruthenium
K. pneumoniae 2.00 2.00 2.00 2.00 2.00 1.00
A. baumannii 1.00 1.12 1.50 1.50 1.50 2.00
E. faecium 0.75 0.75 0.56 1.00 1.00 0.48
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with protoporphyrin and mesoprotoporphyrin respectively have
showed up to 90% antibacterial eﬃcacy against Staphylococcus epi-
dermis and Pseudomonas aeruginosa (Ma et al., 2013). However, in our
work zinc and gallium were not the most antimicrobial metal ion so-
lutions tested. In contrast to our results, indium compounds with cur-
cumin and diacetylcurcumin and yttrium (III) complex with phenan-
throline (at 0.05mg L−1) have also been shown to have low MICs
(187 μgmL−1 to 23 μgmL−1) against E. coli, S. aureus, P. aeruginosa, B.
subtilis and S. epidermidis (Tajbakhsh et al., 2008). Our study also
showed some antimicrobial eﬃcacies for the tantalum metal ion solu-
tions. The addition of niobium to copper (3.8%) has been shown to
decrease the bacterial count by up to 99% against E. coli using viable
bacterial count test (Baena et al., 2006). However, in our study, the
antimicrobial eﬃcacy of the niobium metal ion solutions were not
signiﬁcant in the MIC and MBC tests. Overall, E. faecium was the most
resistant bacteria in the individual ion metal ions, but was the most
sensitive bacteria in the FBC assays whereas for K. pneumonia and A.
baumannii, the opposite was found.
5. Conclusion
Overall, the rhodium metal ion solution demonstrated the best an-
timicrobial eﬃcacy against the three tested bacteria. Only the rhodium/
ruthenium combination showed synergism antimicrobial eﬃcacies
speciﬁcally against E. faecium. This fundamental study suggests that
speciﬁc metal ion combinations used either individually possess the
potential to be used as antimicrobials/biocides.
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